Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310087 (2-chloro-6-fluoro-N-[1-(3-trifluoromethylbenzenesu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.88E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310124 ((S)-2-phenyl-N-(5-(m-tolylsulfonyl)-5,6,7,8-tetrah...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 414 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310089 (US10377768, Compound 3 | US9657033, Compound 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.80E+4 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310090 (US10377768, Compound 4 | US9657033, Compound 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310091 (US10377768, Compound 5 | US9657033, Compound 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.61E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310092 (US9657033, Compound 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.41E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310093 (US10377768, Compound 7 | US9657033, Compound 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.44E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310094 (US10377768, Compound 8 | US9657033, Compound 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.06E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310095 (US10377768, Compound 9 | US9657033, Compound 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.52E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310096 (US10377768, Compound 10 | US9657033, Compound 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.63E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310097 (US10377768, Compound 11 | US9657033, Compound 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 447 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310098 (2-chloro-6-fluoro-N-[1-(4-fluorobenzenesulfonyl)-2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 250 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310099 (2-chloro-6-fluoro-N-[1-(4-fluorobenzenesulfonyl)-2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 174 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310100 ((S)-2-chloro-6-fluoro-N-(3-methyl-1-(m-tolylsulfon...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 166 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310101 ((S)-2-chloro-N-(1-((3-ethylphenyl)sulfonyl)-3-meth...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310102 ((S)-N-(3-(acetamidomethyl)-1-(m-tolylsulfonyl)-2,3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 336 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310103 ((S)-N-((S)-3-(Acetamidomethyl)-1-(m-tolylsulfonyl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 760 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310105 (US10377768, Compound 19 | US9657033, Compound 19) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310106 (US10377768, Compound 20 | US9657033, Compound 20) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 390 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310107 (US10377768, Compound 21 | US9657033, Compound 21) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310108 (US10377768, Compound 22 | US9657033, Compound 22) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310109 (US10377768, Compound 23 | US9657033, Compound 23) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310110 (US10377768, Compound 24 | US9657033, Compound 24) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 132 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310111 (US10377768, Compound 25 | US9657033, Compound 25) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310112 (US10377768, Compound 26 | US9657033, Compound 26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 829 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310113 (US10377768, Compound 27 | US9657033, Compound 27) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310114 (US10377768, Compound 28 | US9657033, Compound 28) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 810 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310115 (US10377768, Compound 29 | US9657033, Compound 29) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.05E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310122 (2,6-difluoro-N-(5-(4-fluorobenzenesulfonyl)-5,6,7,...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 700 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310123 (2-chloro-6-fluoro-N-(5-(m-tolylsulfonyl)-5,6,7,8-t...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 52 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM310088 (2-chloro-6-fluoro-N-[1-(4-fluorobenzenesulfonyl)-1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a |
Lycera Corporation; Merck Sharp & Dohme Corp. US Patent | Assay Description Recombinant,HIS-tagged RORγ-LBD was expressed in SF9 cells using a baculovirus expression system. Cells were lysed and the lysate was used as a ... | US Patent US9657033 (2017) BindingDB Entry DOI: 10.7270/Q24Q7X2T | |||||||||||
More data for this Ligand-Target Pair |